Glenmark Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE935A01035
  • NSEID: GLENMARK
  • BSEID: 532296
INR
2,270.25
-25.75 (-1.12%)
BSENSE

Aug 11

BSE+NSE Vol: 91.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 780863,
    "name": "Glenmark Pharma",
    "stock_name": "Glenmark Pharma",
    "full_name": "Glenmark Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/glenmark-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,270.25",
    "chg": -25.75,
    "chgp": "-1.12%",
    "dir": -1,
    "prev_price": "2,296.00",
    "mcapval": "64,066.64 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532296,
    "symbol": "GLENMARK",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE935A01035",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "91.34 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/glenmark-pharma-780863-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Beyond generics: Glenmark resets agenda with a bold 10-year pivot to global drug innovation, says chairman Saldanha",
        "link": "https://news.google.com/rss/articles/CBMijAJBVV95cUxPZU56d2dPRXRweGxPWmNpZmFwOFYydm0yTmlNTTFKUkFCT1FxZFpQNDY5WGNUTWxUUEV4TEs0dHpGazE4UUxsU2Y4aHFfUkJpOUZKUXNObFFXeXdzNUtLVDctalhrVlJfM0g5ZUlwam1zelZsb1kxcG90cl9ieTc1NWdtN0theUcyem9HM0R4MTVVOUZ3WHNMdXgwMU5jdTVtcThQWUUzWXg5ZWxnTHAxbXhiUXJYZmlRX3lRQUVvckJ1VTlxQUZKeHpFZFFabmRkcDk3eUNRdzBzZ3RteWhzTGpKQ3hKQUxHa0JXeHhjN0NlMVBJZW5mY1RHelBIWkRVd2NJZi1XRnZNczA40gGSAkFVX3lxTE80WHBaVVBQU1lFR0drMG9hTkxqRkloT2NTS1FWcXNiakE2WlNJaEVYZkl3NzJDWmNTOTlUOXNMTTYteFBjTmZjVWxxTUhNSktjbFFjeVEwVG5wVFdQV3ZJV0lKNXhxakZlX0Q0THNYVW94YnplUlUtZlFKWWJEcjEwNFhMSHJZbzNhaXpoanlTaHZBMDJFdXBfamZWQ3dKLWZHazBOOHlvNlFWVXllX3VkODhMbnI0RXhmd2tYYXVzbFlKdDRoN0FrZjRSQ2REQkVDcnRzUFVrWVl4SkNROHJ5SzdSSWVmQm50V3gxOUlIcjAzRHRlR1Y4cENxS3VBN1NQTU8wNVB1MF9jMVlwM1BzY2c?oc=5",
        "imagepath": "",
        "date": "2026-07-07 15:30:57",
        "description": "Beyond generics: Glenmark resets agenda with a bold 10-year pivot to global drug innovation, says chairman Saldanha  livemint.com..."
      },
      {
        "title": "Glenmark Pharmaceuticals Ltd stays supported",
        "link": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQTlBGY01mMFRGUkFnX1ZMd3ZuZlF6VjMtcUFETWVyWjhMYmtfcGpub094TEdCbTdhT18yekMwaUY3bUlDelM5Q0tUd0VUUXI1S2pNcmNXNDdJbmI3dWZSb1ZiR1dpam8xZy1La1B3MmF1WkJZY21LNU02WElQZEpVRDMyc2RKQklwNU0wU2U5MVVKcXExcmNTV2V5VWdvc29vVlJONXQ2SGFteTNoRWF0MmU3NElQOFV6ckxxN20wVFd3MW9G0gHKAUFVX3lxTFBhMkZmWHd5OTQ5V3RtXzU0d1BqX0NQampMbFFtdGxIRDJDcnVjX01zanRseDVmc0dQMktXWTM5MFN1X0VrZVpqUGxsLXpFQWI0RERJSUFhZk8wWDhrbUlITmE5X0gtaVFxYXRuSjFBNXZOQmxPN0NzSi1LWVBnUEVUVjNKN2RwcXB0OTQ3dk94Rm1jZEJ3dlI4SnFuOElyQVktemVaeE52UW5xRGJMdTFXeWxtd0ZUMmltZG5QMFg4bGJLbURZTWdteFE?oc=5",
        "imagepath": "",
        "date": "2026-07-06 14:51:38",
        "description": "Glenmark Pharmaceuticals Ltd stays supported  Business Standard..."
      },
      {
        "title": "Glenmark Pharma jumps over 2% on launch of Olanzapine single-dose vial",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 11:41:16",
        "description": "Glenmark Pharma jumps over 2% on launch of Olanzapine single-dose vial  Business Standard..."
      },
      {
        "title": "Glenmark Pharma jumps over 2% on launch of Olanzapine single-dose vial",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 11:41:16",
        "description": "Glenmark Pharma jumps over 2% on launch of Olanzapine single-dose vial  Business Standard..."
      },
      {
        "title": "Glenmark launches generic schizophrenia, bipolar disorder drug in US",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 10:41:02",
        "description": "Glenmark launches generic schizophrenia, bipolar disorder drug in US  Business Standard..."
      },
      {
        "title": "Glenmark Pharma gains as US arm launches generic Olanzapine injection",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 09:51:33",
        "description": "Glenmark Pharma gains as US arm launches generic Olanzapine injection  Business Standard..."
      },
      {
        "title": "Glenmark Pharma gains as US arm launches generic Olanzapine injection",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 09:51:33",
        "description": "Glenmark Pharma gains as US arm launches generic Olanzapine injection  Business Standard..."
      },
      {
        "title": "Shriram Finance, Glenmark, PCBL Chem: Top stocks to buy  Target prices, stop loss & more",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-01 08:33:56",
        "description": "Shriram Finance, Glenmark, PCBL Chem: Top stocks to buy  Target prices, stop loss & more  Business Today..."
      },
      {
        "title": "Glenmark Pharma arm launches generic Methylene Blue Injection in US market",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-06-17 15:05:18",
        "description": "Glenmark Pharma arm launches generic Methylene Blue Injection in US market  Business Standard..."
      }
    ],
    "total": 11,
    "sid": "780863",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/glenmark-pharmaceuticals-780863"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "07-Aug-2026",
      "details": "Intimation of Schedule of Analyst / Institutional Investor Meetings",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "Newspaper Advertisement regarding the 48th Annual General Meeting (\"the AGM\") to held through Video Conferencing (\"VC\")/ Other Audio-Visual Means (\"OAVM\")",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "05-Aug-2026",
      "details": "Transcript of the Earnings Call",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has declared <strong>250%</strong> dividend, ex-date: 31 Aug 26",
          "dt": "2026-08-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has announced <strong>1:2</strong> stock split, ex-date: 10 Sep 07",
          "dt": "2007-09-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

07-Aug-2026 | Source : BSE

Intimation of Schedule of Analyst / Institutional Investor Meetings

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Aug-2026 | Source : BSE

Newspaper Advertisement regarding the 48th Annual General Meeting ("the AGM") to held through Video Conferencing ("VC")/ Other Audio-Visual Means ("OAVM")

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

05-Aug-2026 | Source : BSE

Transcript of the Earnings Call

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Glenmark Pharmaceuticals Ltd. has declared 250% dividend, ex-date: 31 Aug 26

stock-summary
SPLITS

Glenmark Pharmaceuticals Ltd. has announced 1:2 stock split, ex-date: 10 Sep 07

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available